Cerity Partners’s CONMED CNMD Stock Holding History

Cerity Partners’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$346K	Buy	10,576 +3,909	+59%	+$141K	﹤0.01%	2696
2026 Q1	$236K	Buy	+6,667	New	+$271K	﹤0.01%	2775
2025 Q4	–	Sell	-8,493	Closed	-$399K	–	2900
2025 Q3	$399K	Sell	8,493 -1,915	-18%	-$99.3K	﹤0.01%	2111
2025 Q2	$542K	Sell	10,408 -81	-0.8%	-$4.45K	﹤0.01%	1814
2025 Q1	$633K	Buy	+10,489	New	+$676K	﹤0.01%	1641
2023 Q3	–	Sell	-2,065	Closed	-$281K	–	1450
2023 Q2	$281K	Buy	2,065 +1,429	+225%	+$174K	﹤0.01%	1413
2023 Q1	$1.39M	Buy	+636	New	+$61.5K	﹤0.01%	845
2021 Q2	–	Sell	-2,010	Closed	-$262K	–	712
2021 Q1	$262K	Sell	2,010 -784	-28%	-$94.4K	0.01%	593
2020 Q4	$313K	Hold	2,794	–	–	0.01%	507
2020 Q3	$220K	Buy	+2,794	New	+$228K	0.01%	454

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cerity Partners's CNMD Position: Q2 2026 in Review

Cerity Partners increased its CONMED (CNMD) stake by 59% in Q2 2026, buying an estimated $141K and bringing the position to 10,576 shares worth $346K. The position accounts for ﹤0.01% of the portfolio, ranked #2696.

Cerity Partners first reported a position in CNMD in Q3 2020 and has held it in 10 quarters since. The position peaked at $1.39M in Q1 2023. 211 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

Cerity Partners held 10,576 shares of CONMED worth $346K as of Q2 2026.
Cerity Partners bought 3,909 CONMED shares in Q2 2026, an estimated $141K.
CONMED made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2696 holding.
Cerity Partners first reported a position in CONMED in Q3 2020 and has held it in 10 quarters since.
Cerity Partners's CONMED position peaked at $1.39M in Q1 2023.
211 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.